Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01855672 · ClinicalTrials.gov registry record · Phase 1
Occipital Nerve Stimulation in the Treatment of Migraine
A Phase 1 study, sponsored by Ethicon.
- Terminated
- Registry status
- Phase 1
- Development phase
- 1
- Enrollment target
NCT01855672 is a Phase 1 study that was terminated before completion, run by Ethicon. The registered enrollment target is 1 participants.
The verdict
NCT01855672, a Phase 1 study, was terminated before completion, sponsored by Ethicon.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 1 participants
- Enrollment target
Study Summary
The objective of this proof-of-concept study is to generate initial safety and effectiveness data for the neuro-modulation stimulation (NMS) E-Box in patients with chronic migraine in an acute setting. The results of this study will determine if further development of this device in a larger study is warranted.
Interventions
- DEVICE Stimulation of the Occipital Nerves
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2013-04 |
| Est. Completion | 2013-07 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01855672
The ClinicalTrials.gov registry entry for NCT01855672 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ethicon, which has 38 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Stimulation of the Occipital Nerves is the first listed.
NCT01855672 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01855672 about?
NCT01855672 is a clinical study titled "Occipital Nerve Stimulation in the Treatment of Migraine". The objective of this proof-of-concept study is to generate initial safety and effectiveness data for the neuro-modulation stimulation (NMS) E-Box in patients with chronic migraine in an acute setting. The results of this study will determine if further development of this device in a larger study i...
What is the current status of trial NCT01855672?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 1 participants. The study started on 2013-04. Estimated completion is 2013-07.
What interventions are being tested in trial NCT01855672?
The interventions under investigation include: Stimulation of the Occipital Nerves (DEVICE).
Who is sponsoring clinical trial NCT01855672?
This trial is sponsored by Ethicon, which has 38 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.